<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166457">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01854398</url>
  </required_header>
  <id_info>
    <org_study_id>1-2013-0021</org_study_id>
    <nct_id>NCT01854398</nct_id>
  </id_info>
  <brief_title>The Effect of Continuous Positive Airway Pressure on Diastolic Function in Patients With Obstructive Sleep Apnea</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The association of obstructive sleep apnea (OSA) and cardiac diastolic dysfunction have been
      reported, and improvement of diastolic function after continuous positive airway pressure
      (CPAP) in OSA patients was observed. However, more detailed analysis of diastolic function
      by supine bicycle exercise echocardiography is lacking. The investigators hypothesized that
      3 months of CPAP therapy in OSA patients will significantly improve diastolic functional
      parameters measured by exercise stress echocardiography. Patients with severe OSA
      (Apnea-hypopnea index &gt; 30) will be included in this study, and randomized to CPAP versus
      sham-CPAP group by 1:1 ratio. Supine bicycle exercise echocardiography, pulse wave velocity,
      24 hours ambulatory blood pressure (BP), central BP will be checked before and after CPAP
      therapy and parameters will be compared.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The differences of supine bicycle exercise echocardiographic parameters and PWV before and after CPAP therapy, and between CPAP group and sham CPAP group.</measure>
    <time_frame>after 3 months intervention (CPAP)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The differences of supine bicycle exercise echocardiogrphic parameters (diastolic function grade, mitral inflow parameters, mitral tissue doppler parameters, E/E') and PWV before and after CPAP therapy, and between CPAP group and sham CPAP group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>CPAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-CPAP group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP group</intervention_name>
    <description>Enrolled patients are randomized to CPAP group or sham-CPAP group by 1:1 ratio. The patients in each group will undergo CPAP or sham-CPAP for 3 months.</description>
    <arm_group_label>CPAP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham-CPAP group</intervention_name>
    <description>Enrolled patients are randomized to CPAP group or sham-CPAP group by 1:1 ratio. The patients in each group will undergo CPAP or sham-CPAP for 3 months. Sham CPAP consists of a CPAP machine that is modified to include a large hidden leak in the exhaust port of the mask to disperse the therapeutic pressure.</description>
    <arm_group_label>sham-CPAP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patietns≥20 and ≤75 years-old

          -  Patients who diagnosed as obstructive sleep apnea and AHI&gt;30 on polysomnography

        Exclusion Criteria:

          -  Age &lt; 20 years-old

          -  Left ventricular dysfunction (LVEF&lt;50%) or structural heart disease on transthoracic
             echocardiography

          -  Diabetes mellitus

          -  Significant cardiac valvular disease (≥moderate)

          -  Severe hypertension (&gt;180/110mmHg)

          -  Moderate or severe kidney disease (eGFR &lt; 60 mL/min )

          -  Clinically significant liver disease

          -  History of coronary artery disease

          -  malignancy or autoimmune disease

          -  Acute/chronic infection status

          -  Pregnant status

          -  Patients taking anxiolytics or sedatives
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Geu-Ru Hong, MD, PhD</last_name>
    <phone>082)-02)-2228-8460</phone>
    <email>GRHONG@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geu-Ru Hong, MD, PhD</last_name>
      <phone>082)-02)-2228-8460</phone>
      <email>GRHONG@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>May 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Continuous positive airway pressure</keyword>
  <keyword>diastolic function</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
